Annual EBIT
-$45.41 M
-$5.51 M-13.81%
31 December 2023
Summary:
Cardiff Oncology annual earnings before interest & taxes is currently -$45.41 million, with the most recent change of -$5.51 million (-13.81%) on 31 December 2023. During the last 3 years, it has fallen by -$26.11 million (-135.23%). CRDF annual EBIT is now -1980.64% below its all-time high of -$2.17 million.CRDF EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$12.60 M
-$56.00 K-0.45%
30 September 2024
Summary:
Cardiff Oncology quarterly earnings before interest & taxes is currently -$12.60 million, with the most recent change of -$56.00 thousand (-0.45%) on 30 September 2024. Over the past year, it has dropped by -$1.78 million (-16.46%). CRDF quarterly EBIT is now -682.62% below its all-time high of $2.16 million, reached on 31 December 2018.CRDF Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$46.41 M
-$1.78 M-3.99%
30 September 2024
Summary:
Cardiff Oncology TTM earnings before interest & taxes is currently -$46.41 million, with the most recent change of -$1.78 million (-3.99%) on 30 September 2024. Over the past year, it has dropped by -$1.94 million (-4.36%). CRDF TTM EBIT is now -6345.97% below its all-time high of -$720.00 thousand, reached on 31 March 2011.CRDF TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.8% | -16.5% | -4.4% |
| 3 y3 years | -135.2% | -80.1% | -78.2% |
| 5 y5 years | -176.3% | -199.5% | -353.8% |
CRDF EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -135.2% | at low | -80.1% | at low | -78.2% | at low |
| 5 y | 5 years | -176.7% | at low | -213.1% | at low | -353.8% | at low |
| alltime | all time | -1980.6% | at low | -682.6% | at low | -6346.0% | at low |
Cardiff Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.60 M(+0.4%) | -$46.41 M(+4.0%) |
| June 2024 | - | -$12.54 M(+14.7%) | -$44.63 M(+0.8%) |
| Mar 2024 | - | -$10.93 M(+5.8%) | -$44.29 M(-2.5%) |
| Dec 2023 | -$45.41 M(+13.8%) | -$10.33 M(-4.5%) | -$45.41 M(+2.1%) |
| Sept 2023 | - | -$10.82 M(-11.4%) | -$44.47 M(+4.3%) |
| June 2023 | - | -$12.21 M(+1.3%) | -$42.65 M(+4.3%) |
| Mar 2023 | - | -$12.05 M(+28.3%) | -$40.88 M(+2.5%) |
| Dec 2022 | -$39.90 M(+38.3%) | -$9.39 M(+4.4%) | -$39.90 M(-0.3%) |
| Sept 2022 | - | -$8.99 M(-13.9%) | -$40.04 M(+5.2%) |
| June 2022 | - | -$10.44 M(-5.7%) | -$38.04 M(+10.3%) |
| Mar 2022 | - | -$11.07 M(+16.3%) | -$34.49 M(+19.5%) |
| Dec 2021 | -$28.86 M(+49.5%) | -$9.53 M(+36.1%) | -$28.86 M(+10.8%) |
| Sept 2021 | - | -$7.00 M(+1.6%) | -$26.05 M(+11.3%) |
| June 2021 | - | -$6.89 M(+26.6%) | -$23.41 M(+13.5%) |
| Mar 2021 | - | -$5.44 M(-19.0%) | -$20.62 M(+6.8%) |
| Dec 2020 | -$19.30 M(+17.6%) | -$6.72 M(+53.9%) | -$19.30 M(+16.2%) |
| Sept 2020 | - | -$4.36 M(+6.4%) | -$16.61 M(+0.9%) |
| June 2020 | - | -$4.10 M(-0.5%) | -$16.46 M(-0.7%) |
| Mar 2020 | - | -$4.12 M(+2.5%) | -$16.58 M(+1.0%) |
| Dec 2019 | -$16.41 M(-0.1%) | -$4.03 M(-4.3%) | -$16.41 M(+60.5%) |
| Sept 2019 | - | -$4.21 M(-0.3%) | -$10.23 M(-10.7%) |
| June 2019 | - | -$4.22 M(+6.5%) | -$11.45 M(+4.3%) |
| Mar 2019 | - | -$3.96 M(-283.2%) | -$10.98 M(-6.8%) |
| Dec 2018 | -$16.44 M(-31.2%) | $2.16 M(-139.8%) | -$11.78 M(-28.6%) |
| Sept 2018 | - | -$5.43 M(+45.1%) | -$16.49 M(+7.7%) |
| June 2018 | - | -$3.75 M(-21.3%) | -$15.31 M(-12.3%) |
| Mar 2018 | - | -$4.76 M(+87.1%) | -$17.45 M(-17.3%) |
| Dec 2017 | -$23.87 M | -$2.55 M(-40.2%) | -$21.10 M(-18.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$4.25 M(-27.8%) | -$25.72 M(-18.1%) |
| June 2017 | - | -$5.89 M(-29.9%) | -$31.39 M(-11.5%) |
| Mar 2017 | - | -$8.41 M(+17.3%) | -$35.48 M(-5.5%) |
| Dec 2016 | -$37.53 M(+48.5%) | -$7.17 M(-27.8%) | -$37.53 M(-0.6%) |
| Sept 2016 | - | -$9.92 M(-0.6%) | -$37.75 M(+10.3%) |
| June 2016 | - | -$9.98 M(-4.6%) | -$34.23 M(+10.9%) |
| Mar 2016 | - | -$10.46 M(+41.6%) | -$30.88 M(+22.2%) |
| Dec 2015 | -$25.27 M(+69.1%) | -$7.38 M(+15.2%) | -$25.26 M(+6.9%) |
| Sept 2015 | - | -$6.41 M(-3.2%) | -$23.64 M(+6.4%) |
| June 2015 | - | -$6.62 M(+36.6%) | -$22.21 M(+33.7%) |
| Mar 2015 | - | -$4.85 M(-15.8%) | -$16.61 M(+11.2%) |
| Dec 2014 | -$14.95 M(+26.7%) | -$5.76 M(+15.5%) | -$14.95 M(+46.4%) |
| Sept 2014 | - | -$4.99 M(+387.6%) | -$10.21 M(+6.1%) |
| June 2014 | - | -$1.02 M(-67.9%) | -$9.62 M(-30.6%) |
| Mar 2014 | - | -$3.18 M(+212.2%) | -$13.86 M(+17.5%) |
| Dec 2013 | -$11.79 M(+2.0%) | -$1.02 M(-76.8%) | -$11.79 M(-37.7%) |
| Sept 2013 | - | -$4.39 M(-16.6%) | -$18.93 M(+21.6%) |
| June 2013 | - | -$5.27 M(+374.4%) | -$15.57 M(+13.4%) |
| Mar 2013 | - | -$1.11 M(-86.4%) | -$13.73 M(-0.4%) |
| Dec 2012 | -$11.57 M(+429.9%) | -$8.15 M(+684.5%) | -$13.78 M(+141.3%) |
| Sept 2012 | - | -$1.04 M(-69.7%) | -$5.71 M(+5.7%) |
| June 2012 | - | -$3.43 M(+194.7%) | -$5.40 M(+105.9%) |
| Mar 2012 | - | -$1.16 M(+1300.7%) | -$2.63 M(+20.3%) |
| Dec 2011 | -$2.18 M(-59.4%) | -$83.00 K(-88.7%) | -$2.18 M(+4.0%) |
| Sept 2011 | - | -$732.20 K(+13.1%) | -$2.10 M(+53.5%) |
| June 2011 | - | -$647.40 K(-10.1%) | -$1.37 M(+89.9%) |
| Mar 2011 | - | -$720.00 K | -$720.00 K |
| Dec 2010 | -$5.38 M | - | - |
FAQ
- What is Cardiff Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cardiff Oncology?
- What is Cardiff Oncology annual EBIT year-on-year change?
- What is Cardiff Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cardiff Oncology?
- What is Cardiff Oncology quarterly EBIT year-on-year change?
- What is Cardiff Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cardiff Oncology?
- What is Cardiff Oncology TTM EBIT year-on-year change?
What is Cardiff Oncology annual earnings before interest & taxes?
The current annual EBIT of CRDF is -$45.41 M
What is the all time high annual EBIT for Cardiff Oncology?
Cardiff Oncology all-time high annual earnings before interest & taxes is -$2.17 M
What is Cardiff Oncology annual EBIT year-on-year change?
Over the past year, CRDF annual earnings before interest & taxes has changed by -$5.51 M (-13.81%)
What is Cardiff Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of CRDF is -$12.60 M
What is the all time high quarterly EBIT for Cardiff Oncology?
Cardiff Oncology all-time high quarterly earnings before interest & taxes is $2.16 M
What is Cardiff Oncology quarterly EBIT year-on-year change?
Over the past year, CRDF quarterly earnings before interest & taxes has changed by -$1.78 M (-16.46%)
What is Cardiff Oncology TTM earnings before interest & taxes?
The current TTM EBIT of CRDF is -$46.41 M
What is the all time high TTM EBIT for Cardiff Oncology?
Cardiff Oncology all-time high TTM earnings before interest & taxes is -$720.00 K
What is Cardiff Oncology TTM EBIT year-on-year change?
Over the past year, CRDF TTM earnings before interest & taxes has changed by -$1.94 M (-4.36%)